Sexually Transmitted Disease (STD) Diagnosis Market
Sexually Transmitted Disease (STD) Diagnosis Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus and Others), By Product (Laboratory Testing Devices and Point-Of-Care Testing Devices), By End-User (Hospitals and Clinics, Diagnostic Centers and Homecare) Forecast Period, (2026-2035)
Industry Overview
Sexually transmitted disease (STD) diagnosis market valued at $6,403.2 million in 2025 and is projected to reach $12,854.3 million by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The global sexually transmitted disease (STD) diagnosis market is expanding as healthcare systems and public health organizations intensify efforts toward early detection and effective disease management. Growth is being driven by the rising prevalence of infections such as chlamydia, gonorrhea, syphilis, and HIV, along with increasing awareness regarding routine screening and preventive care. The market is further supported by advancements in molecular diagnostics, point-of-care testing, and rapid immunoassay technologies that enable faster and more accurate detection. Additionally, government-led screening programs and global health initiatives are encouraging widespread testing adoption. As healthcare providers emphasize timely diagnosis and treatment to reduce transmission rates, diagnostic solutions are becoming essential in improving patient outcomes and controlling disease spread.
Market Dynamics
Rising Emphasis on Early Detection and Preventive Screening Programs
Healthcare authorities and public health agencies are increasingly prioritizing early diagnosis of sexually transmitted infections to limit disease transmission and reduce long-term health complications. Growing awareness campaigns, routine screening initiatives, and expanded access to diagnostic services are encouraging individuals to undergo regular testing. Diagnostic providers are focusing on developing user-friendly and rapid testing solutions that can be deployed across clinics, laboratories, and community healthcare settings. As prevention-oriented healthcare strategies gain momentum globally, demand for reliable and accessible STD diagnostic solutions continues to increase.
Advancements in Molecular Diagnostics and Point-of-Care Testing
Technological progress in nucleic acid amplification tests (NAATs), rapid test kits, and multiplex assays is significantly enhancing the accuracy and efficiency of STD diagnosis. These innovations enable simultaneous detection of multiple pathogens with high sensitivity, reducing turnaround times and improving clinical decision-making. The integration of portable and point-of-care diagnostic devices is also expanding testing capabilities in remote and resource-limited settings. Companies are investing in automated platforms and digital reporting systems to streamline workflows and improve scalability. As a result, the adoption of advanced diagnostic technologies is emerging as a key driver of global market growth.
Market Segmentation
- Based on the disease type, the market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus and others.
- based on the product, the market is segmented into laboratory testing devices and point-of-care testing devices.
- based on the end-user, the market is segmented into hospitals and clinics, diagnostic centers and homecare.
Laboratory Testing Devices Segment to Dominate the Market with the Largest Share
In the global sexually transmitted disease (STD) diagnosis market, the laboratory testing devices segment is expected to account for the largest market share, driven by the high accuracy, reliability, and widespread adoption of laboratory-based diagnostic methods. Techniques such as molecular diagnostics, nucleic acid amplification tests (NAATs), and immunoassays are extensively used in clinical settings for the detection of a wide range of STDs. The increasing prevalence of sexually transmitted infections, along with growing awareness regarding early and accurate diagnosis, is further fueling demand for laboratory testing solutions. Additionally, advancements in automated diagnostic platforms and integration of high-throughput technologies are enhancing testing efficiency and scalability. These factors collectively strengthen the dominance of laboratory testing devices within the overall market.
Human Immunodeficiency Virus (HIV): A Key Segment in Market Growth
The human immunodeficiency virus (HIV) segment plays a pivotal role in driving growth within the STD diagnosis market, owing to the significant global burden of HIV infections and the continuous emphasis on early detection and disease management. Governments and global health organizations are actively implementing screening programs and awareness initiatives to promote regular testing and reduce transmission rates. The availability of advanced diagnostic technologies, including rapid tests and confirmatory assays, has improved accessibility and accuracy of HIV diagnosis. Furthermore, increasing investments in healthcare infrastructure, particularly in emerging economies, are expanding access to testing services. Together, these factors position the HIV segment as a major contributor to overall market expansion.
Regional Outlook
The global sexually transmitted disease (STD) diagnosis market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Expanding Public Health Initiatives Across Asia-Pacific
The Asia-Pacific region is witnessing substantial growth in the STD diagnosis market as governments and healthcare organizations strengthen disease surveillance and screening infrastructure. Increasing investments in diagnostic laboratories, awareness programs, and sexual health education are contributing to higher testing rates. Collaborative efforts between public and private sectors are also enhancing access to affordable diagnostic solutions. Furthermore, the rising burden of sexually transmitted infections in densely populated countries is prompting the adoption of rapid and scalable diagnostic technologies. These developments are supporting the region’s expanding role in the global market.
North America Region Dominates the Market with Major Share
North America holds a dominant position in the STD diagnosis market due to its advanced healthcare infrastructure and strong focus on early disease detection. The region benefits from widespread availability of sophisticated diagnostic technologies and well-established laboratory networks. High awareness levels, routine screening practices, and supportive reimbursement frameworks are encouraging the adoption of STD testing solutions. Additionally, continuous innovation by diagnostic companies and strong regulatory oversight are improving test accuracy and reliability. Together, these factors reinforce North America’s leading market position.
Market Players Outlook
The major companies operating in the global sexually transmitted disease (STD) diagnosis market includes Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In July 2025, Abbott Laboratories introduced an advanced molecular diagnostic assay for rapid detection of multiple sexually transmitted infections, enhancing laboratory efficiency and diagnostic accuracy.
- In May 2025, Hologic, Inc. expanded its Panther system capabilities with new assays for chlamydia and gonorrhea testing, aimed at improving high-throughput screening and workflow automation in clinical laboratories.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global sexually transmitted disease (STD) diagnosis Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis – Disease Type | Product | End-User ($ Million)
- Sexually Transmitted Disease (STD) Diagnosis Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sexually Transmitted Disease (STD) Diagnosis Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sexually Transmitted Disease (STD) Diagnosis Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Sexually Transmitted Disease (STD) Diagnosis Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Sexually Transmitted Disease (STD) Diagnosis Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Sexually Transmitted Disease (STD) Diagnosis Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sexually Transmitted Disease (STD) Diagnosis Market Revenue and Share by Manufacturers
- Sexually Transmitted Disease (STD) Diagnosis Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Becton, Dickinson and Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hoffmann-La Roche Ltd
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hologic, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- QIAGEN N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis by Disease Type ($ Million)
- Chlamydia
- Syphilis
- Gonorrhea
- Herpes Simplex Virus
- Human Papilloma Virus
- Human Immunodeficiency Virus
- Others
- Global Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis by Product ($ Million)
- Laboratory Testing Devices
- Point-Of-Care Testing Devices
- Global Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis by End-User ($ Million)
- Hospitals and Clinics
- Diagnostic Centers
- Homecare
- Regional Analysis
- North American Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis – Disease Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis – Disease Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis – Disease Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Sexually Transmitted Disease (STD) Diagnosis Market Sales Analysis – Disease Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cepheid
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chembio Diagnostics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- DiaSorin S.p.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genetic Signatures Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LumiraDx Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- OraSure Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QIAGEN N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QuidelOrtho Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Seegene Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sekisui Diagnostics, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Trinity Biotech plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Visby Medical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Disease Type, 2025–2035 ($ Million)
2. Global Chlamydia Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Syphilis Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Gonorrhea Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Herpes Simplex Virus Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Human Papilloma Virus Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Human Immunodeficiency Virus Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Others Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025–2035 ($ Million)
10. Global Laboratory Testing Devices Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Point-Of-Care Testing Devices Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025–2035 ($ Million)
13. Global Sexually Transmitted Disease (STD) Diagnosis for Hospitals and Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Sexually Transmitted Disease (STD) Diagnosis for Diagnostic Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Sexually Transmitted Disease (STD) Diagnosis for Homecare Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
17. North American Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Country, 2025–2035 ($ Million)
18. North American Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Disease Type, 2025–2035 ($ Million)
19. North American Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025–2035 ($ Million)
20. North American Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025–2035 ($ Million)
21. European Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Country, 2025–2035 ($ Million)
22. European Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Disease Type, 2025–2035 ($ Million)
23. European Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025–2035 ($ Million)
24. European Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025–2035 ($ Million)
25. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Country, 2025–2035 ($ Million)
26. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Disease Type, 2025–2035 ($ Million)
27. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025–2035 ($ Million)
28. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025–2035 ($ Million)
29. Rest of the World Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
30. Rest of the World Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Disease Type, 2025–2035 ($ Million)
31. Rest of the World Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025–2035 ($ Million)
32. Rest of the World Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Disease Type, 2025 Vs 2035 (%)
2. Global Chlamydia Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
3. Global Syphilis Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
4. Global Gonorrhea Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
5. Global Herpes Simplex Virus Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
6. Global Human Papilloma Virus Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
7. Global Human Immunodeficiency Virus Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
8. Global Others Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
9. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Product, 2025 Vs 2035 (%)
10. Global Laboratory Testing Devices Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
11. Global Point-Of-Care Testing Devices Sexually Transmitted Disease (STD) Diagnosis Market Share by Region, 2025 Vs 2035 (%)
12. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by End-User, 2025 Vs 2035 (%)
13. Global Sexually Transmitted Disease (STD) Diagnosis for Hospitals and Clinics Market Share by Region, 2025 Vs 2035 (%)
14. Global Sexually Transmitted Disease (STD) Diagnosis for Diagnostic Centers Market Share by Region, 2025 Vs 2035 (%)
15. Global Sexually Transmitted Disease (STD) Diagnosis for Homecare Market Share by Region, 2025 Vs 2035 (%)
16. Global Sexually Transmitted Disease (STD) Diagnosis Market Research and Analysis by Region, 2025–2035 ($ Million)
17. US Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
18. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
19. UK Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
20. France Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
21. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
22. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
23. Spain Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
24. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
25. Rest of Europe Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
26. India Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
27. China Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
28. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
29. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
30. Australia and New Zealand Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
31. ASEAN Economies Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
32. Rest of Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
33. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
34. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
